Dear Editor,

We are submitting a revision of our paper entitled "In silico Identification and in vitro and in vivo Validation of Anti-Psychotic Drug Fluspirilene as a Potential CDK2 Inhibitor and a Candidate Anti-Cancer Drug" for your consideration as an original research article.

In this revision, we have revised our manuscript according to the reviewers' comments, and answered all the questions raised by the two reviewers. Please see our uploaded "Response to Reviewers" file.

Yours Sincerely,

Hongjian Li, on behalf of the co-authors.
